LANTHEUS HOLDINGS ($LNTH) posted quarterly earnings results for Q4 2025 on Thursday, February 26th. The company reported earnings of $1.67 per share, beating estimates of $1.19 by $0.48. The company also reported revenue of $406,790,000, beating estimates of $375,176,063 by $31,613,937.
You can see Quiver Quantitative's $LNTH stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LANTHEUS HOLDINGS Hedge Fund Activity
We have seen 173 institutional investors add shares of LANTHEUS HOLDINGS stock to their portfolio, and 361 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- M&T BANK CORP added 5,518,444 shares (+inf%) to their portfolio in Q4 2025, for an estimated $367,252,448
- MORGAN STANLEY removed 2,120,583 shares (-54.7%) from their portfolio in Q4 2025, for an estimated $141,124,798
- FARALLON CAPITAL MANAGEMENT LLC added 1,950,252 shares (+56.1%) to their portfolio in Q4 2025, for an estimated $129,789,270
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,495,072 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $76,682,242
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,293,935 shares (-72.1%) from their portfolio in Q4 2025, for an estimated $86,111,374
- ASSENAGON ASSET MANAGEMENT S.A. removed 1,208,111 shares (-94.4%) from their portfolio in Q4 2025, for an estimated $80,399,787
- BRIGADE CAPITAL MANAGEMENT, LP removed 1,137,773 shares (-89.9%) from their portfolio in Q4 2025, for an estimated $75,718,793
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
LANTHEUS HOLDINGS Government Contracts
We have seen $43,671,779 of award payments to $LNTH over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- FLUORINE 18 PIFLUFOLASTAT - PYLARIFY: $2,490,016
- PYLARIFY - CLEVELAND VAMC: $2,268,623
- PYLARIFY RADIOPHARM: $2,115,883
- PYLARIFY: $1,814,360
- RADIOPHARMACEUTICAL PYLARIFY: $1,811,577
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
LANTHEUS HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $LNTH in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/18/2025
- Mizuho issued a "Outperform" rating on 12/17/2025
- B. Riley Securities issued a "Buy" rating on 09/16/2025
- TD Cowen issued a "Buy" rating on 09/15/2025
To track analyst ratings and price targets for LANTHEUS HOLDINGS, check out Quiver Quantitative's $LNTH forecast page.
LANTHEUS HOLDINGS Price Targets
Multiple analysts have issued price targets for $LNTH recently. We have seen 6 analysts offer price targets for $LNTH in the last 6 months, with a median target of $79.0.
Here are some recent targets:
- David Turkaly from Citizens set a target price of $78.0 on 02/24/2026
- Richard Newitter from Truist Securities set a target price of $82.0 on 12/18/2025
- Anthony Petrone from Mizuho set a target price of $72.0 on 12/17/2025
- Paul Choi from Goldman Sachs set a target price of $77.0 on 10/08/2025
- Justin Walsh from B. Riley Securities set a target price of $84.0 on 09/16/2025
- Tara Bancroft from TD Cowen set a target price of $80.0 on 09/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
